Disruption of the RB pathway and cell-proliferative activity in non- small-cell lung cancers

International Journal of Cancer

Volumn 79, Issue 2, 1998, Pages 111-115

  Tanaka, Hisaichi ^a   Fujii, Yoshitaka ^b   Hirabayashi, Hirohisa ^a   Miyoshi, Shinichiro ^a   Sakaguchi, Masahiro ^a   Yoon, Hyung Eun ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL ACTIVITY; CELL CYCLE G1 PHASE; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; METHYLATION; PRIORITY JOURNAL;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETINOBLASTOMA PROTEIN;

EID: 0031895370     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980417)79:2<111::AID-IJC2>3.0.CO;2-W     Document Type: Article

References (21)

1. BETTICHER, D.C., HEIGHWAY, J., HASLETON, P.S., ALTERMATT, H.J., RYDER, W.D.J., CERNY, T. and THATCHER, N., Prognostic significance of CCND1 (cyclinD1) over-expression in primary resected non-small-cell lung cancer. Brit. J. Cancer, 73, 294-300 (1996).
2. BORG, Å., JOHANSSON, U., JOHANNSSON, O., HÅKANSSON, S., WESTERDAHL, J., MÅSBÄCK, A., OLSSON, H. and CHRISTIAN, I., Novel germline p16 mutation in familial malignant melanoma in Southern Sweden. Cancer Res., 56, 2497-2500 (1996).
3. CHIBA, I. and 13 OTHERS, Mutations in the p53 gene are frequent in primary, resected non-small-cell lung cancer. Oncogene, 5, 1603-1610 (1990).
4. DAKSIS, J.I., LU, R.Y., FACCHINI, L.M., MARHIN, W.W. and PENN, L.J.Z., myc induces cyclin-D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene, 9, 3635-3645 (1994).
5. FILMUS, J., ROBLES, A.I., SHI, W., WONG, M.J., COLOMBO, L.L. and CONTI, C.J., Induction of cyclin-D1 over-expression by activated ras. Oncogene, 9, 3627-3633 (1994).
6. INK4 or retinoblastoma protein (pRB), or amplification-associated over-expression of cdk4 is observed in distinct sub-sets of malignant glial tumors and cell lines. Cancer Res., 55, 4833-4836 (1995).
7. JARES, P. and 13 OTHERS, Expression of retinoblastoma gene product (pRb) in mantle-cell lymphomas. Correlation with cyclin D1 (prad1/ccnd1) mRNA levels and proliferative activity. Amer. J. Pathol., 148, 1591-1600 (1996).
8. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S. III, JOHNSON, B.E. and SCOLNICK, M., A cell-cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
9. INK4A and retinoblastoma protein status in non-small-cell lung cancer: Potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res., 56, 5557-5562 (1996).
10. INK4a expression in resected non-small-cell lung tumors. Cancer Res., 56, 3415-3420 (1996).
11. LUKAS, J., PARRY, D., AAGAARD, L., MANN, D.J., BARTKOVA, J., STRAUSS, M., PETERS, G. and BARTEK, J., Retinoblastoma-protein-dependent cell- cycle inhibition by the tumor suppressor p16. Nature (Lond.), 375, 503-506 (1995).
12. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/ CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692 (1995).
13. MÜLLER, H., LUKAS, J., SCHNEIDER, A., WARTHOE, P., BARTEK, J., EILERS, M. and STRAUSS, M., Cyclin-D1 expression is regulated by the retinoblastoma protein. Proc. nat. Acad. Sci. (Wash.), 91, 2945-2949 (1994).
14. REISSMANN, P.T., KOGA, H., TAKAHASHI, R., FIGLIN, R.A., HOLMES, E.C., PIANTADOSI, S., CORDON-CARDO, C. and SLAMON, D.J. and the Lung-Cancer Study Group, Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. Oncogene, 8, 1913-1919 (1993).
15. SAKAGUCHI, M., FUJII, Y., HIRABAYASHI, H., YOON, H.-E., KOMOTO, Y., OUE, T., KUSAFUKA, T., OKADA, A. and MATSUDA, H., Inversely correlated expression of p16 and Rb protein in non-small-cell lung cancers: An immunohistochemical study. Int. J. Cancer, 65, 442-445 (1996).
16. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4. Nature (Lond.), 366, 704-707 (1993).
17. INK4 expression in primary lung cancers and cell lines. Cancer Res., 55, 505-509 (1995).
18. SHERR, C.J., Cancer cell cycles. Science, 274, 1672-1677 (1996).
19. WESTON, A., WILLEY, J.C., MODALI, R., SUGIMURA, H., MCDOWELL, E.M., RESAU, J., LIGHT, B., HAUGEN, A., MANN, D.D., TRUMP, B.F. and HARRIS, C.C., Differential DNA-sequence deletions from chromosomes 3, 11, 13 and 17 in squamous-cell carcinoma, large-cell carcinoma and adenocarcinoma of the human lung. Proc. nat. Acad. Sci. (Wash.), 86, 5099-5193 (1989).
20. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 269, 1281-1284 (1995).
21. XU, H.-J., HU, S.-X., CAGLE, P.T., MOORE, G.E. and BENEDICT, W.F., Absence of retinoblastoma protein expression in primary non-small-cell lung carcinomas. Cancer Res., 51, 2735-2739 (1991).